| [1] |
Darbari A, Sabin KM, Shapiro CN, Schwarz KB. Epidemiology of primary hepatic malignancies in U.S. children. Hepatology. 2003;38(3):560–6. doi: 10.1053/jhep.2003.50375 |
| [2] |
Zhou S, Venkatramani R, Gupta S, Wang K, Stein JE, Wang L, et al. Hepatocellular malignant neoplasm, NOS: a clinicopathological study of 11 cases from a single institution. Histopathology. 2017;71(5):813–22. doi: 10.1111/his.13297 |
| [3] |
Prokurat A, Kluge P, Kościesza A, Perek D, Kappeler A, Zimmermann A. Transitional liver cell tumors (TLCT) in older children and adolescents: a novel group of aggressive hepatic tumors expressing beta-catenin. Med Pediatr Oncol. 2002;39(5):510–8. doi: 10.1002/mpo.10177 |
| [4] |
Eichenmüller M,, Trippel F, Kreuder M, Beck A, Schwarzmayr T, Häberle B, et al. The genomic landscape of hepatoblastoma and their progenies with HCC-like features. J Hepatol 2014;61(6):1312–20. doi: 10.1016/j.jhep.2014.08.009 |
| [5] |
Seng MS, Berry B, Karpelowsky J, Thomas G, Mews C, Stormon M, et al. Successful treatment of a metastatic hepatocellular malignant neoplasm, not otherwise specified with chemotherapy and liver transplantation. Pediatr Blood Cancer. 2019;66(4):e27603. doi: 10.1002/pbc.27603 |
| [6] |
Katzilakis N, Tsirigotaki M, Stratigaki M, Kampouraki E, Athanasopoulos E, Markaki EA, et al. Second malignant neoplasms in children and adolescents treated for blood malignancies and solid tumors: a single-center experience of 15 years. Indian J Med Paediatr Oncol. 2018;39:483–7. doi: 10.4103/ijmpo.ijmpo_102_17 |
| [7] |
Ozcan HN, Oguz B, Salim T, Talim B, Haliloglu M. A rare malignant hepatic tumor of childhood: transitional liver cell tumor revisited. JBR-BTR. 2015;98(2):79–81. |
| [8] |
Ertel AE, Fu B, Shah SA. Mixed transitional liver cell tumor in a 23-year-old female: a case report. Semin Roentgenol. 2016 Apr;51(2):123–5. doi: 10.1053/j.ro.2016.02.006 |
| [9] |
Katzilakis NTsirigotaki M, Stratigaki M, Kampouraki E, Athanasopoulos E, Markaki EA, et al. Second malignant neoplasms in children and adolescents treated for blood malignancies and solid tumors: a single-center experience of 15 years. Indian J Med Paediatr Oncol. 2018;39:483–7. doi: 10.4103/ijmpo.ijmpo_102_17 |
| [10] |
Canberk S, Uludokumaci A, Sonmez C, Cakalir C, Gulsen F, Ozbay G. Mixed hepatocellular carcinoma and hepatoblastoma: cytohistopathologic findings and differential diagnosis. Acta Cytol. 2013;57(1):91–5. doi: 10.1159/000339275 |
| [11] |
Papry A, Kamal M, Khalid MS. Hepatoblastoma in a child with dextrocardia and possible histopathological alteration reminiscent of hepatocellular carcinoma after neoadjuvant chemotherapy. Clin Case Rep. 2018 Apr 17;6(6): 1070–3. |
| [12] |
López-Terrada D, Alaggio R, de Dávila MT, Czauderna P, Hiyama E, Katzenstein H, et al. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol. 2014;27(3):472–91. doi: 10.1038/modpathol.2013.80 |
| [13] |
Chavhan GB, Siddiqui I, Ingley KM, Gupta AA. Rare malignant liver tumors in children. Pediatr Radiol. 2019;49(11):1404–21. doi: 10.1007/s00247-019-04402-8 |